Respiratory Trials·org

ARDS · Oxygenation targets

LOCO2

Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome

LOCO2 trial design and results
Design Randomised trial, stopped early for safety
Treatment Conservative oxygenation, PaO2 55 to 70 mmHg
Control Liberal oxygenation, PaO2 90 to 105 mmHg
Population 201 analysed patients with ARDS
Follow-up 90 days
Primary endpoint Death at 28 days
Result Death at day 28 in 34 of 99 (34.3%) in the conservative-oxygen group versus 27 of 102 (26.5%) in the liberal-oxygen group — difference 7.8 percentage points. The trial was stopped early by the data and safety monitoring board for safety concerns and low likelihood of a significant difference. Five episodes of mesenteric ischaemia occurred in the conservative group.
Secondary endpoints 90-day mortality, mesenteric ischaemia, organ failure

Among patients with ARDS, early exposure to a conservative-oxygenation strategy with a Pao2 between 55 and 70 mm Hg did not increase survival at 28 days.

The trial authors, in the published abstract

How it has aged

Stopped for safety, with a mortality signal in the wrong direction and five cases of mesenteric ischaemia. It marks the lower bound of permissive hypoxaemia: tolerating a PaO2 in the 50s as a target, rather than as a consequence, is not supported.

Publications

Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome

Barrot L, Asfar P, Mauny F, et al. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. N Engl J Med 2020 Mar 12;382(11):999-1008.

  • 28-day mortality numerically higher with conservative oxygen targets
  • Five episodes of mesenteric ischaemia in the conservative group
  • Stopped early by the data and safety monitoring board